AHA GUIDELINES Bundle (free trial)

Dyslipidemia 2026

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1543908

Contents of this Issue

Navigation

Page 98 of 105

99 Comments • Use is restricted to patients with HoFH • Available only through a restricted REMS program that ensures safe use requiring regular monitoring of liver function and other health parameters • Use is restricted to patients with HoFH • Infusion rate can be slowed, interrupted, or discontinued if signs of adverse reactions, including infusion or hypersensitivity reactions are present during administration

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Dyslipidemia 2026